Skip to main content
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.
- Author(s): Logan, Aaron
- Logan, AC
- Zhang, B
- Narasimhan, B
- Carlton, V
- Zheng, J
- Moorhead, M
- Krampf, MR
- Jones, CD
- Waqar, AN
- Faham, M
- et al.
Published Web Location
http://europepmc.org/articles/PMC3740398?pdf=renderNo data is associated with this publication.
Abstract
Quantification of minimal residual disease (MRD) following allogeneic hematopoietic cell transplantation (allo-HCT) predicts post-transplant relapse in patients with chronic lymphocytic leukemia (CLL). We utilized an MRD-quantification method that amplifie
Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.